ACAndrew T. Ching

Andrew T. Ching

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Andrew T. Ching has a total of 26 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Estimating Position and Social Influence Effects in Online Search

    by Ata Jameei Osgouei, Andrew T. Ching, Brian T. Ratchford, Shervin Shahrokhi Tehrani

    This paper estimates position and social influence effects in online search using a structural model and field experiment data.


  • Heterogeneous Complementarity and Team Design: The Case of Real Estate Agents

    by Yan Xu, Mantian Hu, Junhong Chu, Andrew T. Ching

    Heterogeneous complementarity between workers with different (unobserved) characteristics significantly impacts teamwork and the design of effective teams.


  • Consumption Responses to an Unpopular Policy: Evidence from a Short-Lived Soda Tax

    by Andrew T. Ching, Daniel Goetz

    This paper provides evidence that consumers who disagree with a soda tax decrease their consumption more strongly to avoid the tax burden.


  • How Does a Firm Adapt in a Changing World? The Case of Prosper Marketplace

    by Xinlong Li, Andrew T. Ching

    We propose a generalized revealed preference approach to infer how agents use past data to adapt in a changing environment.


  • A Heuristic Approach to Explore: The Value of Perfect Information

    by Shervin Shahrokhi Tehrani, Andrew T. Ching

    This research introduces a new heuristic decision model called myopic-value of perfect information (VPI) to study multiarmed bandit (MAB) problems. The myopic-VPI approach only involves ranking the alternatives and computing a one-dimensional integration to obtain the expected future value of exploration. Because myopic-VPI is intuitive and does not involve solving a dynamic programming problem, it has the potential to serve as a useful heuristic approach to model exploration-exploitation tradeoffs. We conduct a series of simulation experiments to study its performance relative to other heuristics under a wide range of parameterizations. We find that myopic-VPI provides significant savings in computational time and decent performance in accumulated utility (although not the strongest) relative to other forward-looking heuristics; this suggests that it is a useful “fast-and-frugal” heuristic. Furthermore, our simulation experiments also reveal the conditions under which myopic-VPI outperforms and underperforms compared with other heuristics. Its empirical performance in the diaper category further shows that myopic-VPI can save estimation time significantly and fit the data on par with index and near-optimal, providing encouraging news that myopic-VPI could be added to the researcher’s or practitioner’s toolkit for MAB problems. This paper was accepted by Gui Liberali, marketing. Supplemental Material: The online appendices are available at https://doi.org/10.1287/mnsc.2019.00578 .


  • Does Bad Medical News Reduce Preferences for Generic Drugs?

    by Manuel Hermosilla, Andrew T. Ching

    Policy makers and insurers promote the use of generic drugs because they can deliver large savings without sacrificing quality. But these efforts meet resistance from the public, who perceive generic drugs as inferior substitutes for brand name counterparts. Building on literature showing that negative emotions reduce risk-taking, the authors hypothesize that receiving bad medical news (i.e., negative information about one’s health) prompts patients to favor brand name over generic drugs as means to safeguard their health. The evidence exploits low-density lipoprotein cholesterol test results, where a discontinuity from clinical guidelines enables the authors to estimate the causal effect of bad medical news. Using data covering patients’ prescription drug choices across drug classes, the authors find that patients receiving bad medical news become 8% more likely to choose the brand name alternative. The findings are reinforced by a secondary analysis incorporating the similar context of hemoglobin A1c (blood sugar) testing. The authors also find that bad medical news reduces preferences for generics most strongly among drugs of direct clinical relevance for each test, but the effect also manifests among non–clinically relevant drugs.


  • Complementarity of Information Products

    by Andrew T. Ching, Ignatius Horstmann, Hyunwoo Lim

    In “Marketing Information: A Competitive Analysis,” Sarvary, M., and P. M. Parker. 1997. “Marketing Information: A Competitive Analysis.” Marketing Science 16 (1): 24–38 (S&P) argue that in part of the parameter space that they considered, a reduction in the price of one information product can lead to an increase in demand for another information product, i.e. information products can be gross complements. This result is surprising and has potentially important marketing implications. We show that S&P obtain this complementarity result by implicitly making the following internally inconsistent assumptions: (i) after purchasing information products, consumers update their beliefs using a Bayesian updating rule that assumes they have a diffuse initial prior (i.e. their initial prior variance is ∞ before receiving any information); (ii) if consumers choose not to purchase any information product, it is assumed that their initial prior variance is 1 (implied by the utility function specification). This internal inconsistency leads to the possibility that when information products are uncorrelated and their variances are close to 1, marginal utility is increasing in the number of products purchased, and hence information products can be complements in their model. We show that if we remove this internal inconsistency, in the parameter space considered by S&P, information products cannot be complements because the marginal utility of information products will be diminishing. We also show that, in parts of the parameter space not considered by S&P, it is possible that information products are complements; this space of parameters requires consumer’s initial prior to be relatively precise and information products to be highly correlated (either positively or negatively).

  • Identification and Estimation of Forward-Looking Behavior: The Case of Consumer Stockpiling

    by Andrew T. Ching, Matthew Osborne

    Understanding how forward-looking consumers respond to price promotions in storable goods markets is an important area of research in empirical marketing and industrial organization. In prior work, researchers have assumed that consumers in these markets are very forward-looking, and calibrated their weekly discount factors to levels around 0.9995. This calibration has been used because earlier research has assumed that a consumer’s storage cost is a continuous function of inventory, which rules out exclusion restrictions that can be used to identify the discount factor. We show that by properly modeling storage cost as a step function of inventory (because storage cost depends on the number of packages stored, instead of the actual amount of inventory), natural exclusion restrictions arise that allow for the discount factor to be point identified. In an application to a storable good category, we find that weekly discount factors are very heterogeneous across consumers, and are on average 0.71. We show through a counterfactual exercise that if one used a model that fixed the discount factor to be consistent with the standard calibrated value, one would overpredict the effect of increased promotional depth for a product on its quantity sold by 18% in the short term, and 15% in the long term.


  • A Structural Model of Correlated Learning and Late-Mover Advantages: The Case of Statins

    by Andrew T. Ching, Hyunwoo Lim

    We propose a structural model of correlated learning with indirect inference to explain late-mover advantages. Our model focuses on a class of products with the following two features: (i) products that build on a common fundamental technology (e.g., computer processor, car, smartphone, etc.) and (ii) that consumers can observe some product attributes of a product (e.g., CPU clock speed, horsepower of a car engine, screen size of a smartphone, etc.), but when making their purchase decisions, consumers are not sure how efficiently the product can translate its observed attributes to performing tasks that they care about. For products that base on a similar technology, it is plausible that consumers use the information signals of one product’s technological efficiency to help them update their belief about another product’s technological efficiency within the same product category. As a result, a late entrant could benefit from the information spillover generated by an early entrant. We apply our framework to the statin market in Canada, where drugs rely on a similar mechanism to reduce the cholesterol level. In our model, patients/doctors can observe a statin’s efficacy in reducing the cholesterol level, but they are uncertain about how effectively it can convert its cholesterol-reducing ability to reducing heart disease risks. Our estimation results show that the combination of correlated learning and informative and persuasive detailing explain the success of the two late entrants in the statin market: Lipitor and Crestor. This paper was accepted by Matthew Shum, marketing.


  • Open Access

    Structural Models of the Prescription Drug Market

    by Andrew T. Ching, Manuel Hermosilla, Qiang Liu

    We survey the literature on structural models for the prescription drug market, which has attracted significant attention from researchers in marketing and economics, and related fields. The literature has evolved from adopting standard structural models developed for other markets to models that are specifically designed to capture the institutional details of the prescription drug market. Along the way, these empirical frameworks have not only greatly improved in terms of explaining stylized facts, but also in terms of producing better counterfactual predictions. Topics covered by this survey include the application of learning models to explain slow diffusion, post-patent expiry competition, prepatent expiry competition, R&D and new drug introduction, managerial and public policy analysis, and the economics of the Medicare Part-D program. We conclude by discussing future research directions.